Stock listing

B3:HYPE3 Hypera S.A. Ações

Home listing (B3) of Hypera S.A.

Follow Hypera S.A. into a list and get an email when it puts out news.

Share price · BMFBOVESPA:HYPE3

21.77 BRL -0.56 (-2.5%)

Close on Nov 19, 2026

Past year -14.4% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
21.52 – 22.19 BRLNov 19, 2026
Volume
3.37M sharesNov 19, 2026
Market cap
15.33B BRLAt the close on Nov 19, 2026 · price × 704.0M shares outstanding
52-week range
19.41 – 30.00 BRLLowest and highest trades, Nov 21, 2025 – Nov 19, 2026
Traded on an average day
99.70M BRLMedian day 3.37M shares · last 3 months, Aug 19, 2026 – Nov 19, 2026
Hypera S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
B3:HYPE3 · Home21.77 BRL-0.56 (-2.5%)3,368,30021.9822.1921.5222.33Close on Nov 19, 2026
OTC:HYPMY$3.74 USD+0.045 (+1.2%)200$3.74$3.74$3.74$3.695Close on Nov 20, 2026
Frankfurt:HM6A€3.26 EUR-0.06 (-1.8%)—€3.26€3.26€3.26€3.32Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · BMFBOVESPA:HYPE3 · BRL, adjusted for splits

DayCloseChange%OpenHighLowVolume
21.77-0.56-2.5%21.9822.1921.523,368,300
22.33+0.13+0.6%22.2522.7622.151,413,800
22.20-0.27-1.2%22.4622.5021.912,364,800
22.47+0.26+1.2%22.2622.5522.075,387,900
22.21-0.25-1.1%22.4522.4921.992,432,700
22.46+0.29+1.3%22.0522.5822.051,463,500
22.17-0.31-1.4%22.6622.6621.962,091,400
22.48+0.37+1.7%22.2922.6522.162,034,700
22.11+0.25+1.1%21.9422.3021.454,001,400
21.86+0.19+0.9%21.7521.9021.383,943,600
21.67+0.61+2.9%21.2421.7520.835,102,400
21.06-0.21-1.0%20.9721.0620.554,546,900
21.27-0.25-1.2%21.2721.6520.957,289,200
21.52-0.22-1.0%21.7422.1721.348,177,500
21.74+0.29+1.4%21.9622.5721.4612,774,200
21.45+0.89+4.3%20.7621.5920.679,603,500
20.56-6.69-24.6%20.4321.5219.4113,550,400
27.25+0.77+2.9%26.5427.2626.464,612,900
26.48-0.33-1.2%26.7326.8426.223,763,800
26.81-0.44-1.6%27.3327.5126.572,545,200
27.25+1.06+4.0%26.5227.5426.463,931,700
26.19+0.59+2.3%25.7626.7125.763,844,200
25.60+0.15+0.6%25.6425.7725.173,646,500
25.45-0.33-1.3%25.2626.2125.182,746,500
25.78-0.22-0.8%25.6625.8925.185,165,900
26.00-0.93-3.5%26.5226.7125.706,115,800
26.93+0.23+0.9%26.9627.2526.535,649,900
26.70-0.62-2.3%27.2127.3426.4911,319,700
27.32+0.32+1.2%27.2027.7327.075,066,300
27.00+0.05+0.2%26.9927.9226.845,823,500
26.95+1.79+7.1%25.9630.0025.908,518,300
25.16+0.51+2.1%25.3325.3424.723,069,300
24.65+0.17+0.7%24.6825.0224.434,311,800
24.48+0.75+3.2%23.8524.7123.745,485,900
23.73-0.90-3.7%24.4324.4423.703,161,900
24.63+0.10+0.4%24.4424.6724.121,874,300
24.53-0.10-0.4%24.4724.8524.432,360,000
24.63+0.26+1.1%24.5524.6824.272,429,100
24.37-0.62-2.5%24.6925.1024.372,485,600
24.99+0.87+3.6%23.9924.9923.777,167,700
24.12+0.32+1.3%23.9524.3323.695,148,500
23.80+0.21+0.9%23.4423.9023.232,668,200
23.59+0.04+0.2%23.5723.8623.121,701,100
23.55+0.17+0.7%23.3423.7723.292,319,200
23.38-0.15-0.6%23.6323.7023.203,134,800
23.53+0.77+3.4%22.2323.5922.003,134,400
22.76-0.08-0.4%22.7423.1922.647,477,700
22.84+0.25+1.1%22.4523.0022.331,565,900
22.59-0.49-2.1%22.7423.0022.521,385,800
23.08-0.08-0.3%23.3923.7522.992,495,500
23.16+0.43+1.9%22.7423.2822.313,603,000
22.73+0.27+1.2%22.7923.1822.502,622,100
22.46+0.71+3.3%21.9622.5921.694,352,100
21.75+0.05+0.2%21.7922.2621.732,299,300
21.70+0.34+1.6%21.6521.8221.382,736,500
21.36+0.11+0.5%21.2421.4820.952,578,800
21.25-0.76-3.5%21.8222.0021.254,816,500
22.01+0.21+1.0%21.8822.2921.842,789,500
21.80+0.38+1.8%21.5121.8721.353,810,200
21.42+0.25+1.2%20.8821.6020.812,728,500
21.17+0.44+2.1%20.8321.4120.473,355,500
20.73-0.06-0.3%20.5920.9020.422,050,000
20.79+0.07+0.3%21.0221.1020.633,276,000

Splits

1 split · BMFBOVESPA:HYPE3 · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
Ticker
B3:HYPE3
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
B3
Currency
BRL

What changed lately

Latest news

All Hypera S.A. news

Hypera S.A. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
3 in the last 12 months · 6 in all · newest Apr 28, 2026 · oldest 2025
Calls
17 calls with a replay · 17 with a transcript · latest Aug 7, 2026
Decks
17 decks · latest Aug 7, 2026

Where Hypera S.A. is listed

ListingExchangeCountryCurrency
B3:HYPE3 · Home listing · This pageB3BrazilBRL
B3:HYPE3FB3BrazilBRL
OTC:HYPMYOTCUnited StatesUSD
LS Exchange:A2JETELS ExchangeGermanyEUR
Lang & Schwarz:A2JETELang & SchwarzGermanyEUR
Frankfurt:HM6AFrankfurtGermanyEUR
Stuttgart:HM6AStuttgartGermanyEUR

Valuation

P/E 8.5× against a median of 21.9×: the lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 19, 2026

Enterprise value
21.11B BRL
P/E
8.5×
EV/sales
2.3×
EV/EBITDA
7.4×
Price/book
1.0×
Gross margin
58.9%
Operating margin
28.0%
Net margin
20.1%
Debt to equity
0.5×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Hypera S.A. · BMFBOVESPA:HYPE3US$2.59BUS$3.57B8.5×2.3×7.4×1.0×20.1%0.5×n/a
China Medical System Holdings Ltd. · HKEX:867US$2.87BUS$2.13B12.8×1.7×7.7×1.1×18.1%0.1×n/a
Joincare Pharmaceutical Group Industry Co., Ltd. Class A · SSE:600380US$2.80BUS$1.16B16.5×0.6×n/a1.3×8.4%0.1×n/a
Livzon Pharmaceutical Group, Inc. Class A · SZSE:000513US$2.72BUS$1.65B11.7×1.1×n/a1.4×15.2%0.0×n/a
Bavarian Nordic A/S · OMXCOP:BAVAUS$2.70BUS$2.38B20.5×2.6×8.6×1.4×14.2%0.0×n/a
Betta Pharmaceuticals Co., Ltd. Class A · SZSE:300558US$2.64BUS$2.72B66.1×4.8×n/a2.7×7.0%0.2×n/a
Hanmi Science Co., Ltd · KRX:008930US$2.60BUS$2.53B23.2×2.5×57.2×3.3×10.8%0.0×n/a
Hybio Pharmaceutical Co., Ltd. Class A · SZSE:300199US$2.60BUS$2.71B43.1×11.8×n/a16.1×26.3%0.9×n/a
Kangmei Pharmaceutical Co., Ltd Class A · SSE:600518US$2.57BUS$2.37B189×3.3×n/a2.3×1.9%0.0×n/a
Granules India Limited · NSE:GRANULESUS$2.42BUS$2.32B31.4×3.6×16.1×3.4×12.1%0.2×n/a
Prestige Consumer Healthcare Inc. · NYSE:PBHUS$2.35BUS$4.39B15.2×3.8×13.4×1.2×13.3%1.1×0.34
Median of the othersUS$2.62BUS$2.37B21.9×2.9×13.4×1.9×12.7%0.1×0.34

Forecasts

Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.

Price target
29.92 BRL · Analysts' mean
EPS, year to Dec 2026
2.67 · 7 analysts
Revenue, year to Dec 2026
9.25B · 11 analysts

Team and board

Officers

OfficerRole
Breno Toledo Pires de OliveiraChief Executive Officer (CEO)
Ramon Sanches Frutuoso SilvaChief Financial Officer (CFO) and IRO
Pharmacy Purchase PriceIR contacts
Adalmario Ghovatto Satheler do CoutoOfficer
Juliana Aguinaga Damião SalemOfficer
Rafael Vito BatistaOfficer

Board

DirectorRole
Álvaro Stainfeld LinkChairman of the Board of Directors
Bernardo Malpica HernándezMember of the Board of Directors
Cláudio Ermirio de MoraesMember of the Board of Directors
Eliana Helena de Gregório Ambrosio ChimentiIndependent Member of the Board of Directors
Esteban Malpica FomperosaMember of the Board of Directors
João Alves de Queiroz FilhoMember of the Board of Directors
João Henrique Batista de Souza SchmidtMember of the Board of Directors
Luciana Cavalheiro Fleischner Alves de QueirozMember of the Board of Directors
Mauro Gentile Rodrigues da CunhaIndependent Member of the Board of Directors
Rachel de Oliveira MaiaIndependent Member of the Board of Directors

Events

Next results
Mar 11, 2027 (expected)

Calls

CallWhenStatus
Hypera (B3:HYPE3) Q2 2026 Earnings CallFri, Aug 07, 2026 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q4 2025 Earnings CallFri, Mar 13, 2026 · 11:00 AM ETReplay
Hypera (B3:HYPE3) Q3 2025 Earnings CallWed, Oct 29, 2025 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q2 2025 Earnings CallThu, Aug 07, 2025 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q1 2025 Earnings CallThu, Apr 24, 2025 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q4 2024 Earnings CallFri, Mar 21, 2025 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q3 2024 Earnings CallThu, Nov 14, 2024 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q2 2024 Earnings CallFri, Jul 26, 2024 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q1 2024 Earnings CallMon, Apr 29, 2024 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q4 2023 Earnings CallThu, Mar 14, 2024 · 10:00 AM ETReplay
All 17 calls
CallWhenStatus
Hypera (B3:HYPE3) Q3 2023 Earnings CallFri, Oct 27, 2023 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q2 2023 Earnings CallFri, Jul 28, 2023 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q1 2023 Earnings CallFri, Apr 28, 2023 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q4 2022 Earnings CallFri, Feb 17, 2023 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q3 2022 Earnings CallFri, Oct 28, 2022 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q2 2022 Earnings CallFri, Jul 29, 2022 · 10:00 AM ETReplay
Hypera (B3:HYPE3) Q1 2022 Earnings CallFri, Apr 29, 2022 · 10:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 27, 2026 · After close+1.4%
Q2 2026Aug 6, 2026 · After close+1.3%
Q1 2026Apr 21, 2026 · After close−2.1%
Q4 2025Mar 11, 2026 · After close−2.3%
Q3 2025Oct 27, 2025 · After close−0.5%
Q2 2025Aug 5, 2025 · After close+0.4%
Q1 2025Apr 23, 2025 · After close+12.3%
Q3 2024Nov 13, 2024 · After close−0.3%
Q2 2024Jul 25, 2024 · After close+5.8%
Q1 2024Apr 25, 2024 · After close+5.2%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 13, 2024 · After close−3.7%
Q3 2023Oct 26, 2023 · After close−8.3%
Q2 2023Jul 27, 2023 · After close−0.2%
Q1 2023Apr 27, 2023 · After close+3.5%
Q4 2022Feb 22, 2023 · After close+0.7%
Q3 2022Oct 27, 2022 · After close+1.7%
Q2 2022Jul 28, 2022 · After close+5.2%
Q1 2022Apr 28, 2022 · After close−1.9%
Q4 2021Feb 24, 2022 · After close+2.8%
Quarter to Sep 30, 2021Oct 21, 2021 · After close−2.1%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings7 slidesAug 7, 2026
Q4 2025 Earnings PresentationEarnings8 slidesMar 13, 2026
Q3 2025 Earnings PresentationEarnings7 slidesOct 29, 2025
Q2 2025 Earnings PresentationEarnings7 slidesAug 7, 2025
Q1 2025 Earnings PresentationEarnings6 slidesApr 24, 2025
Q4 2024 Earnings PresentationEarnings8 slidesMar 21, 2025
Q3 2024 Earnings PresentationEarnings7 slidesNov 14, 2024
Q2 2024 Earnings PresentationEarnings7 slidesJul 26, 2024
Q1 2024 Earnings PresentationEarnings7 slidesApr 29, 2024
Q4 2023 Earnings PresentationEarnings10 slidesMar 14, 2024
All 17 decks
DeckKindSlidesDate
Q3 2023 Earnings PresentationEarnings9 slidesOct 27, 2023
Q2 2023 Earnings PresentationEarnings9 slidesJul 28, 2023
Q1 2023 Earnings PresentationEarnings7 slidesApr 28, 2023
Q4 2022 Earnings PresentationEarnings10 slidesFeb 17, 2023
Q3 2022 Earnings PresentationEarnings8 slidesOct 28, 2022
Q2 2022 Earnings PresentationEarnings9 slidesJul 29, 2022
Q1 2022 Earnings PresentationEarnings8 slidesApr 29, 2022

Open Decks

Financings

RaiseDateIn US dollars
Rights offering of common shares
Announced: BRL 1.15B–BRL 1.5B · BRL 21.25 a share
Buyers: Votorantim S.A. (shares in an amount of up to R$1,000,000,000.00, subject to availability of unsubscribed shares)
Insiders: The controlling shareholder group has undertaken to fully exercise its preemptive rights and take up unsubscribed shares to ensure the Minimum Amount; Votorantim S.A. undertook to subscribe up to R$1,000,000,000.00.
Use of proceeds: Strengthen capital structure by reducing net debt, improving operational efficiency and expanding capacity for organic and inorganic growth.
Feb 3, 2026US$219.86M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in BRL

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue7.70B7.44B7.91B7.55B5.94B4.09B3.29B3.72B3.50B3.23B
Cost of revenue3.35B3.06B2.92B2.78B2.13B1.46B1.21B1.06B926.7M833.3M
Gross profit4.35B4.38B5.00B4.76B3.80B2.63B2.09B2.67B2.57B2.39B
Research and development134.7M145.5M169.5M159.4M126.7M151.7M128.7M73.9M98.8M73.3M
Selling, general and administrative73.2M89.3M84.4M92.8M67.4M48.2M42.8M49.8M172.4M145.7M
Operating income1.74B1.80B2.50B2.46B2.04B1.29B1.09B1.23B1.16B1.03B
Depreciation and amortization317.2M281.1M238.3M169.1M133.7M121.5M120.4M88.9M76.9M72.2M
EBITDA2.05B2.08B2.74B2.63B2.17B1.41B1.21B1.32B1.24B1.10B
Interest expense1.08B1.04B1.35B1.04B383.2M201.3M43.2M46.2M67.5M228.3M
Income before tax900.1M979.2M1.51B1.61B1.64B1.24B1.10B1.23B1.21B835.5M
Income tax-290.8M-353.8M-141.6M-95.3M26.6M-78.2M-88.9M94.5M101.9M188.3M
Net income1.20B1.34B1.65B1.70B1.33B1.30B1.16B1.13B964.9M1.18B
Earnings per share, basic1.862.102.582.652.082.031.821.771.521.84

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.65B1.74B2.58B2.86B2.29B4.74B2.25B1.65B1.52B1.35B
Short-term investments-168.0M-518.3M-834.8M-812.4M-212.8M-303.9M-275.2M
Receivables2.08B2.25B2.65B3.08B2.67B1.57B1.62B1.46B1.22B1.02B
Inventory2.08B1.94B2.19B2.20B1.30B920.8M664.6M596.7M454.8M431.3M
Current assets6.05B6.68B8.08B8.53B6.49B7.90B4.74B4.26B3.93B5.21B
Property, plant and equipment4.23B3.90B3.56B2.82B2.10B1.55B1.17B963.9M906.8M943.7M
Goodwill7.34B7.34B7.34B7.37B7.37B4.31B4.27B4.27B4.27B4.27B
Total assets28.6B24.6B24.5B23.8B19.8B17.2B11.9B10.6B10.1B11.4B
Accounts payable575.7M984.1M389.7M1.31B790.8M275.5M457.8M198.1M178.3M124.9M
Current liabilities4.11B3.94B4.64B5.23B2.78B2.62B1.59B1.41B1.71B1.74B
Long-term debt8.01B7.99B7.82B7.38B6.80B5.05B1.29B457.8M318.5M684.0M
Total debt9.49B9.40B10.1B9.76B7.46B5.59B1.43B582.4M676.0M910.9M
Total liabilities16.1B12.5B13.0B13.1B9.98B8.01B3.21B2.29B2.39B2.68B
Shareholders' equity12.5B12.1B11.5B10.6B9.83B9.24B8.71B8.27B7.74B8.71B
Shares outstanding643.1M637.9M637.8M639.1M639.5M638.3M639.9M639.5M636.4M641.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.43B2.54B2.40B2.04B1.40B1.18B823.9M1.07B932.6M881.8M
Capital spending-532.3M-772.3M-812.7M-1.51B-838.9M-1.93B-361.6M-220.9M-211.9M-214.1M
Free cash flow896.1M1.77B1.58B529.3M560.2M-744.2M462.3M845.6M720.7M667.7M
Cash from investing-690.8M-592.4M-791.2M-1.74B-4.41B-1.90B-306.5M-170.5M659.0M2.45B
Cash from financing-831.3M-2.79B-1.89B279.0M557.1M3.21B82.2M-771.2M-1.42B-4.74B
Dividends paid-627.8M-787.3M-759.9M-806.2M-745.9M-682.5M-623.4M-633.0M-409.8M-316.1M
Share buybacks-23.1M-55.8M-88.5M-87.0M-128.7M12.1M-72.2M-4.28M-1.12B-104.8M
Change in cash-93.8M-841.6M-281.6M575.4M-2.46B2.50B599.6M124.7M174.1M-1.41B

Open Financials

Cap table

Built by 6ix from Hypera S.A.’s releases · as of Feb 3, 2026

Common shares
703,995,955
Fully diluted
703,995,955

Fully diluted

LineShares
Common shares703,995,955

Share count over time

CountShares
Nov 22, 2026703,995,955

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
Calydon Capital713US$3,230NewNov 16, 2026

Register

HolderSharesOf the companyAs of
João Alves De Queiroz Filho183M25.9%Jul 26, 2017
Votorantim S.A115M16.4%Jul 7, 2025
Maiorem S.A. de C.V.93.4M13.3%May 17, 2013
FMR LLC35.3M5.0%Oct 29, 2026
Negotio Magni S.A De C.V10.4M1.5%Aug 16, 2007
Alvaro Stainfeld Link833K0.12%Jul 26, 2017

Funds

HolderSharesValueChangeAs of
Fidelity Low-Priced Stock Fund7.22MUS$30.3MNo changeJul 31, 2026
Vanguard Total International Stock Index Fund5.23MUS$22M+433KJul 31, 2026
Vanguard Emerging Markets Stock Index Fund5.15MUS$21.6M+602KJul 31, 2026
Fidelity Series Emerging Markets Opportunities Fund4.98MUS$20.9M+87,363Jul 31, 2026
iShares Core MSCI Emerging Markets ETF3.58MUS$15.5M+357KMay 31, 2026
Fidelity Emerging Markets Discovery Fund3.14MUS$13.2MNo changeJul 31, 2026
Templeton Emerging Markets Equity Fund2.2MUS$8.86M+236KJun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund1.78MUS$7.73MNo changeMay 31, 2026
Emerging Markets Core Equity 2 Portfolio1.6MUS$6.71MNo changeJul 31, 2026
Fidelity Low-Priced Stock K6 Fund1.31MUS$5.49MNo changeJul 31, 2026
Show 50 holders
HolderSharesValueChangeAs of
iShares MSCI Brazil Small-Cap ETF1.3MUS$5.67M−324KMay 31, 2026
WisdomTree Emerging Markets High Dividend Fund992KUS$3.99M+209KJun 30, 2026
WisdomTree Emerging Markets SmallCap Dividend Fund924KUS$3.71M−10,000Jun 30, 2026
Vanguard Ftse All-World Ex-Us Index Fund856KUS$3.59M+108KJul 31, 2026
Mondrian Global Equity Value Fund709KUS$2.98M−18,300Jul 31, 2026
iShares Core MSCI Total International Stock ETF621KUS$2.6M+7,108Jul 31, 2026
Fidelity Emerging Markets Equity Central Fund538KUS$2.17M−73,896Jun 30, 2026
Vanguard International High Dividend Yield Index Fund465KUS$1.95M+205KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF445KUS$1.86MNo changeJul 31, 2026
Franklin FTSE Brazil ETF436KUS$1.75M+141KJun 30, 2026
Schwab Emerging Markets Equity ETF413KUS$1.79M+42,715May 31, 2026
Templeton Emerging Markets VIP Fund399KUS$1.61M+42,945Jun 30, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF366KUS$1.47M+3,923Jun 30, 2026
The Emerging Markets Small Cap Series339KUS$1.42MNo changeJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF307KUS$1.29MNo changeJul 31, 2026
Dimensional Emerging Markets Value Fund289KUS$1.21MNo changeJul 31, 2026
Emerging Markets Fund286KUS$1.2M−84,200Jul 31, 2026
RBC Emerging Markets Value Equity Fund249KUS$1.01MNo changeJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account241KUS$971K+24,154Jun 30, 2026
Vanguard Total World Stock Index Fund240KUS$1.01MNo changeJul 31, 2026
Fidelity Total International Index Fund213KUS$895K−1,100Jul 31, 2026
Templeton Emerging Markets Small Cap Fund212KUS$919K+22,741May 31, 2026
Avantis Emerging Markets Equity ETF183KUS$800K+18,355May 31, 2026
Dimensional Emerging Markets Value ETF130KUS$545K+2,300Jul 31, 2026
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund129KUS$519K−600Jun 30, 2026
Fidelity ZERO International Index Fund129KUS$539K+13,100Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio96,154US$403KNo changeJul 31, 2026
World ex U.S. Core Equity Portfolio85,887US$360K−18,600Jul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio81,701US$328K+901Jun 30, 2026
iShares MSCI Emerging Markets Small-Cap ETF78,636US$342K−3,202May 31, 2026
Dimensional Emerging Core Equity Market ETF75,057US$314K−13,900Jul 31, 2026
Mondrian Emerging Markets Value Equity Fund73,411US$308K+11,500Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio71,622US$301KNo changeJul 31, 2026
JPMorgan Diversified Return Emerging Markets Equity ETF71,557US$301KNo changeJul 31, 2026
Parametric Tax-Managed Emerging Markets Fund64,000US$258KNo changeJun 30, 2026
World ex U.S. Targeted Value Portfolio61,244US$257KNo changeJul 31, 2026
Vanguard ESG International Stock ETF60,688US$264K+6,088May 31, 2026
Emerging Economies Fund53,144US$231K+27,821May 31, 2026
Franklin FTSE Latin America ETF48,800US$196K+16,110Jun 30, 2026
SMART Mid Cap ETF43,691US$183KFirst reportJun 30, 2026

This page holds 50 of 72 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Adalmario Ghovatto Satheler do CoutoOfficer · Since at least Nov 5, 2026
Álvaro Stainfeld LinkChairman of the Board of Directors · Since at least Aug 6, 2025
Bernardo Malpica HernándezMember of the Board of Directors · Since at least Nov 5, 2026
Breno Toledo Pires de OliveiraChief Executive Officer (CEO) · Since at least Nov 5, 2026
Cláudio Ermirio de MoraesMember of the Board of Directors · Since at least Aug 6, 2025
Eliana Helena de Gregório Ambrosio ChimentiIndependent Member of the Board of Directors · Since at least Oct 28, 2025
Esteban Malpica FomperosaMember of the Board of Directors · Since at least Nov 5, 2026
João Alves de Queiroz FilhoMember of the Board of Directors · Since at least Aug 6, 2025
João Henrique Batista de Souza SchmidtMember of the Board of Directors · Since at least Oct 28, 2025
Juliana Aguinaga Damião SalemOfficer · Since at least Nov 5, 2026
All 16 people
PersonSeat
Luciana Cavalheiro Fleischner Alves de QueirozMember of the Board of Directors · Since at least Oct 28, 2025
Mauro Gentile Rodrigues da CunhaIndependent Member of the Board of Directors · Since at least Oct 28, 2025
Pharmacy Purchase PriceIR contacts · Since at least Apr 28, 2026
Rachel de Oliveira MaiaIndependent Member of the Board of Directors · Since at least Oct 28, 2025
Rafael Vito BatistaOfficer · Since at least Nov 5, 2026
Ramon Sanches Frutuoso SilvaChief Financial Officer (CFO) and IRO · Since at least Feb 3, 2026

Open People

Log in to ask 6ix AI your own questions about Hypera S.A.